Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/01/20 → 31/12/20 |
Funding
- BHP Billiton Group: A$2,665,000.00
To address challenges of the COVID-19 pandemic in Western Australia through research in to the Post-exposure-Prophylaxis Containing Coronavirus trial, to determine if inhaled IFNa2B therapy significantly reduces period of infection
- Stick, Stephen (Chief Investigator)
- Kollmann, Tobias (Investigator 02)